Ultra-deep targeted sequencing to identify HRAS, TP53, and CDKN2A somatic mutations as molecular prognostic markers in patients with advanced oral squamous cell carcinoma.
2015 ◽
Vol 33
(15_suppl)
◽
pp. 6024-6024
2011 ◽
Vol 269
(6)
◽
pp. 1665-1670
◽
Keyword(s):
2019 ◽
Vol 120
(11)
◽
pp. 1084-1085
◽
2019 ◽
Vol 120
(7)
◽
pp. 714-727
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. 6027-6027